Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study

ClinicalTrials.gov ID: NCT02198664

Public ClinicalTrials.gov record NCT02198664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 2, 2026, 4:55 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen (CPNA) Peanut Oral Immunotherapy (OIT) Safety Follow-On Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center, open-label, follow-on study to gather additional information on the safety and tolerability of oral desensitization with CPNA in the subjects who participated in ARC001.

Study identification

NCT ID
NCT02198664
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aimmune Therapeutics, Inc.
Industry
Enrollment
47 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
4 Years to 26 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 27, 2014 (Actual)
Primary completion
Jan 4, 2018 (Actual)
Completion
Jan 4, 2018 (Actual)
Last update posted
Nov 9, 2021

2014 – 2018

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202 —
UC San Diego San Diego California 92123 —
Boston Children's Hospital Boston Massachusetts 02115 —
Mount Sinai Medical Center New York New York 10029 —
University of North Carolina Chapel HIll Chapel Hill North Carolina 25799 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Medical Center Dallas Dallas Texas 75235 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02198664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 9, 2021 · Synced Nov 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02198664 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →